Rigel Pharmaceuticals (RIGL) Prepaid Assets (2010 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly Prepaid Assets came in at $25.7 million in Q1 2026, up 303.8% year-on-year from $6.4 million in Q1 2025, and up 17.34% quarter-over-quarter from $21.9 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Prepaid Assets (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $25.7 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 303.8% year-over-year to $25.7 million in Q1 2026; TTM through Mar 2026 was $25.7 million, a 303.8% increase from a year earlier, with the FY2025 full-year figure at $21.9 million, up 115.86% from the prior year.
- Prepaid Assets rose to $25.7 million in Q1 2026 per RIGL's latest filing, from $21.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $25.7 million in Q1 2026 and bottomed at $3.0 million in Q3 2023.
- The 5-year median for Prepaid Assets is $7.9 million (2022), against an average of $9.2 million.
- Across the five-year window, Prepaid Assets plunged 51.03% in 2023 and surged 303.8% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $8.3 million in 2022, then retreated by 24.19% to $6.3 million in 2023, then jumped by 62.35% to $10.2 million in 2024, then soared by 115.86% to $21.9 million in 2025, then grew by 17.34% to $25.7 million in 2026.
- Per Business Quant, the three latest RIGL Prepaid Assets figures stand at $25.7 million (Q1 2026), $21.9 million (Q4 2025), and $5.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.75 Mn |
| Dec 31, 2025 | 21.94 Mn |
| Sep 30, 2025 | 5.86 Mn |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | 6.38 Mn |
| Dec 31, 2024 | 10.17 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 8.66 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Dec 31, 2023 | 6.26 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 8.26 Mn |
| Sep 30, 2022 | 6.16 Mn |
| Jun 30, 2022 | 7.94 Mn |
| Mar 31, 2022 | 9.42 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 5.93 Mn |
| Jun 30, 2021 | 6.61 Mn |